A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ ... market trends, and industry changes. What are some of the most expensive stocks insiders have ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ ... in the context of a company’s financial health, market trends, and industry changes. What are some of ...